The global tibial neuromodulation devices market is anticipated to witness robust growth, with sales projected to rise at a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2022 to 2032. The market size is expected to be valued at USD 97.7 million in 2022 and is projected to surpass USD 230.7 million by 2032.
Key factors driving the expansion of the tibial neuromodulation devices market include the increasing incidence of urological illnesses, heightened demand for minimally invasive procedures, and the growing trend of outpatient care. These devices are gaining popularity among healthcare professionals as they provide the necessary power, precision, and control for both soft and hard tissue, as well as bone modulation.
As the adoption of tibial neuromodulation devices continues to rise, the market is poised for significant growth, reflecting the evolving landscape of urological treatments and the shift towards more effective, minimally invasive options for patients.
A confluence of factors propels this remarkable growth, including the increasing incidence of urological illnesses, a growing demand for minimally invasive procedures, and the rising trend of outpatient usage. Tibial neuromodulation devices are gaining prominence as they empower surgeons with the precision, power, and control needed for effective soft or hard tissue and bone modulation.
The landscape of healthcare is evolving, and tibial neuromodulation devices are at the forefront of this transformation. Their expanding usage is a testament to the advancements in medical technology, providing patients and healthcare professionals with innovative solutions for better outcomes.
The neuromodulation devices are clinically accessed and provide safe, effective and minimally invasive treatment options. The percutaneous tibial neuromodulation devices are cost-effective and the procedure can be performed in office-based treatment centers. The device is helpful both to the professional and patient as it is portable and inexpensive therapy. The device is tested and is effective in both men and women. The common side effects are the pain, skin inflammation near the stimulation site. The procedure involves to place the electrode needle to the lower side of the leg slightly to the malleolus. The ground pad is fitted to the base of the device and followed to the heel bone on the leg. The patient is treated once per week and completes at least twelve therapy sessions.
Advancement in the tibial neuromodulator devices due to research and development and companies focus on organic growth will support the physicians with the wide range of devices used on an outpatient basis and offers new patients with new treatment procedure where conservative treatments do not work. This advancement will boost the percutaneous tibial neuromodulation devices in the near future
Percutaneous Global Tibial Neuromodulation Devices Industry: Drivers and Restrains
Rising incidence of urological disease, increase in demand for minimally invasive procedure, usage in outpatient basis are the factors favouring market growth over the forecast period. The use of neuromodulator devices is gaining popularity and enabling surgeons the power, precision, and control needed for soft or hard tissue, bone modulation. The factors limiting the market growth is high treatment cost, less awareness about the devices and other treatment options prevailing in the market. Growth opportunities such as increasing market share through mergers and acquisitions and investing in emerging economics, technological advancement in percutaneous tibial neuromodulation devices is boosting the growth of the target market
Percutaneous Global Tibial Neuromodulation Devices Industry: Key Players
Some of the key players in Global Tibial Neuromodulation Devices Industry are Cogentix Medical, Palex Medical SA, Medtronic plc. Rainbow Medical Group and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
Global Tibial Neuromodulation Devices Industry: Segmentation
The Global Tibial Neuromodulation Devices Industry has been classified on the basis of application, end-user, and geography.
Based on the Application, the Global Tibial Neuromodulation Devices Industry is pided into the following:
- Faecal Incontinence
- Overactive Bladder
Based on the End User, the Global Tibial Neuromodulation Devices Industry is pided into following:
- Hospital
- Ambulatory Surgical centers
- Clinics
- Specialty Care Unit
- Others
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
